University Hospitals Harrington Heart & Vascular Institute

Sanjay Rajagopalan Honored with AHA Distinguished Scientist Award Prestigious honor recognizes individuals whose work has significantly advanced the understanding of cardiovascular disease and stroke.

Sanjay Rajagopalan, MD, MBA, Honored with American Heart Association Distinguished Scientist Award @uhcleveland.bsky.social @uhreinstitute.bsky.social

news.uhhospitals.org/news-release...

Don’t miss it! Hands-on training, live cases, debates and more at the Inaugural Cleveland Aortic Symposium: The Root, The Arch, The Works

View Agenda
cwru.cloud-cme.com/Assets/cwru/...

Register Online & Learn More
cwru.cloud-cme.com/course/cours...

UH Receives Highest Designation for Quality Outcomes for Coronary Artery Bypass Grafting 3-star recognition from the Society of Thoracic Surgeons.

The Society of Thoracic Surgeons has awarded @harringtonhvi.bsky.social a 3-star rating, its highest designation, for CABG quality outcomes. Only 20% of hospitals nationally have a 3-star rating. @uhcleveland.bsky.social @sts.org #cardiosky
news.uhhospitals.org/news-release...

Excited to share that my colleagues, Drs Robert Goldstein and Samer de Oliveira, at UH Lake West Hospital are performing Pulsed Field Ablation to treat Afib! @harringtonhvi.bsky.social
@nejm.org nejm.org/doi/full/10.1056/NEJMoa2502280

UH First Site in Ohio to Provide More Accurate and Convenient PET MPI Cardiac Stress Test First-of-its-kind F 18 radiopharmaceutical helps physicians better detect blockages in heart arteries that can lead to heart attacks.

First in Ohio to clinically administer FDA-approved PET MPI agent Flyrcado (flurpiridaz F 18) injection in patients with known or suspected CAD. “One of the most groundbreaking advancements in nuclear cardiology in decades.” #cardiosky

news.uhhospitals.org/news-release...

Novel Aspiration Thrombectomy and Blood Reinfusion System for Acute Intermediate-Risk Pulmonary Embolism: AVENTUS Trial Results Mechanical thrombectomy has become a first-line adjunctive therapy for anticoagulation in patients with acute intermediate-risk pulmonary embolism (PE). This prospective study evaluated the safety and...

"An important advancement in PE care.” – Dr. Jun Li, Co-Director, Vascular Center @harringtonhvi.bsky.social and national co-PI of Inquis Medical’s AVENTUS thrombectomy system shared trial results at @scainews.bsky.social Scientific Sessions @uhreinstitute.bsky.social www.jscai.org/article/S277...

Congratulations Dr Varun Sundaram! Transform-AF presented as a LBCT- demonstrated impact of SGLP-1 on reducing AF with just modest weight loss. A potential gamechanger! TOP 3 #HRS2025 Pacesetter Pick. Saksena commentary “transformative”. @harringtonhvi.bsky.social @heartrhythmsociety.bsky.social

UH Harrington HVI Reunion @HeartRhythm2025
What a night! Alumni/Faculty/Fellows spanning 40 years of EP at UH!!! RIP ALW

Trials at University Hospitals Harrington Heart & Vascular Institute Advance Leadless Pacemakers and Extravascular ICDs | Cleveland, Ohio Innovations in Cardiovascular Medicine & Surgery | March 2025

Extravascular ICDs can address limitations of transvenous ICDs, providing effective defibrillation with improved pacing capabilities. Two investigational exemption trials helped bring novel options to market. @judymackall.bsky.social #cardiosky

www.uhhospitals.org/for-clinicia...